February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health.
Vetoquinol has acquired the Profender® product family, the intellectual property, registrations and other rights from Elanco Animal Health for the Canadian market. This acquisition has been approved by the Canadian Competion Bureau. The Profender® range consists in spot-on de-wormer products for cats.
In August 2020, Vetoquinol acquired the Profender® and Drontal® product families in the EU and the UK in relation to Elanco’s 2020 acquisition of Bayer AG’s animal health business. In January 2021, Vetoquinol also acquired the Profender® and Drontal® product families in Australia.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire Profender® for the Canadian market, one of our prominent strategic countries. The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment. Adding this Essential to our product portfolio in Canada will strengthen our market share in the pet segment in this strategic country.”
Latest news of vetoquinol
15 Apr 2021Q1 2021 SALES: €128M (UP 28% AT CONSTANT EXCHANGE RATES, UP 24% AS REPORTED) Q1 2021 ESSENTIALS SALES: €72.6M (UP 38% AT CONSTANT EXCHANGE...
01 Apr 20212020 sales: €427.5m (up 8.0% as reported) EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%) Net income - Group...